OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206
Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
A feasibility study of neoadjuvant chemotherapy (NAC) followed by interval cytoreductive
surgery (ICS) and postoperative chemotherapy for stage III/IV mullerian carcinomas such as
ovarian, tubal and peritoneal carcinomas.